MedPath

Evaluation of an Anti-TREM-1 Treatment on an ex Vivo Human Intestinal Model

Recruiting
Conditions
Inflammatory Bowel Diseases
Interventions
Other: Additional biopsies and blood samples
Registration Number
NCT06580418
Lead Sponsor
Inotrem
Brief Summary

TIME is an observational study performed on UC and CD patients under endoscopic surveillance for monitoring the clinical activity of their disease.

The main objective of the study is to confirm the therapeutic potential of TREM-1 in inflammatory bowel disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients between 18 and 60 years
  • Signed informed consent
  • Ulcerative colitis (UC) patients with active disease
  • Crohn's disease (CD) patients with active disease
Exclusion Criteria
  • UC or CD patients in remission
  • Patients between 18 and 60 years without informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Crohn's Disease (CD)Additional biopsies and blood samples20 patients with moderate to severe CD under endoscopic surveillance for their disease
Ulcerative colitis (UC)Additional biopsies and blood samples20 patients with moderate to severe UC under endoscopic surveillance for their disease
Primary Outcome Measures
NameTimeMethod
Collection of IBD patient-derived intestinal mucosal explants for testing TREM-1 antagonist20 months

Derivation of RNA and proteins from biopsy specimens upon in vitro exposure to the TREM-1 antagonist

Secondary Outcome Measures
NameTimeMethod
Concentration of pro-inflammatory cytokines in supernatants of treated explants to evaluate the effect of the TREM-1 antagonist compound26 months

Measurement of pro-inflammatory cytokine concentrations (pg/ml)

Gene expression in treated explants and other samples to evaluate the effect of the TREM-1 antagonist compound26 months

RNAseq analysis

Trial Locations

Locations (1)

IRCCS San Raffaele

🇮🇹

Milano, Italy

© Copyright 2025. All Rights Reserved by MedPath